NASDAQ: GNTA - Genenta Science S.p.A.

Lønnsomhet i seks måneder: +57.75%
Sektor: Healthcare

Kampanjeplan Genenta Science S.p.A.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma.

flere detaljer
In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0046
EV/EBITDA 4.39
IPO date 2021-12-15
ISIN US36870W1009
Industry Biotechnology
P/BV 4.54
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.genenta.com
Цена ао 4.4
Число акций ао 0.01822 млрд
Prisendring per dag: -5.24% (5.15)
Prisendring per uke: -2.59% (5.01)
Prisendring per måned: -9.29% (5.38)
Prisendring over 3 måneder: +24.43% (3.922)
Prisendring over seks måneder: +57.75% (3.0936)
Prisendring per år: -1.41% (4.95)
Prisendring over 3 år: 0% (4.88)
Prisendring over 5 år: 0% (4.88)
Prisendring over 10 år: 0% (4.88)
Prisendring siden begynnelsen av året: -0.3492% (4.8971)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 4.11 4
P/E 0 0
EV/EBITDA -7.02 0
Total: 2.75

Effektivitet

Navn Betydning Karakter
ROA, % -51 0
ROE, % -55.78 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 154.8 10
Lønnsomhet EPS, % 575.04 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Bank Julius Baer & Co. Ltd, Zurich 412547 2.26
Algebris (UK) LTD 45000 0.25
UBS Group AG 2301 0.01
Morgan Stanley 500 0



Veileder Stillingstittel Betaling Fødselsår
Dr. Luigi Naldini M.D., Ph.D. Co-Founder & Chairman of the Executive Scientific Board N/A 1959 (66 år)
Dr. Bernard Rudolph Gentner M.D., Ph.D. Co-Founder & Member of the Executive Scientific Board N/A 1975 (50 år)
Mr. Richard B. Slansky Chief Financial Officer N/A 1958 (67 år)
Dr. Carlo Russo M.D. Chief Medical Officer & Head of Development N/A 1953 (72 år)
Dr. Stefania Mazzoleni Ph.D. Director of Program Development N/A 1982 (43 år)
Ms. Barbara Regonini Director of Finance N/A 1973 (52 år)
Mr. Pierluigi Paracchi Co-Founder, Chairman & CEO 1973 (52 år)

Adresse: Italy, Milan, Via Olgettina No. 58 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.genenta.com